PDGFRA and glioblastoma: In addition, The Cancer Genome Atlas (TCGA) classified glioblastomas on the basis of PDGFRA, IDH1, EGFR, and NF1 abnormalities in classical, mesenchymal, proneural, and neural subtypes, and these four subgroups seemed to present distinct outcomes [7–9].